Compare Intel Corp (INTC) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intel Corp vs Moderna, Inc. — how do they compare? Intel Corp trades at $105.45 (market cap $487.82B), while Moderna, Inc. trades at $59.38 (market cap $23.60B). The key difference: Intel Corp is far larger — about 20.7× Moderna, Inc.'s market cap, and Intel Corp pays a 2.24% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| INTC | MRNA | |
|---|---|---|
Market Cap | $487.82B | $23.60B |
Volume | 43,552,012 | — |
Sector | Technology | Health |
52-Week High | $140.94 | $81.80 |
52-Week Low | $19.31 | $22.36 |
Enterprise Value | $500.07B | $19.70B |
Dividend Yield | 2.24% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intel Corp
Intel Corporation designs, manufactures, and sells computer components and related products. The Company major products include microprocessors, chipsets, embedded processors and microcontrollers, flash memory, graphic, network and communication, systems management software, conferencing, and digital imaging products.
Read more on INTC →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
